Asymptomatic microscopic hematuria (AMH) is a common finding and has been considered an important clinical sign of urinary tract malignancy. The definition and guidelines of AMH have changed over the years. Much of the evidence is based on data from male patients and the risk of urinary tract malignancy may be less in women than in men. Women specific conditions may lead to increased incidence of AMH. Likewise, primary care providers appear not to refer many women with AMH. We review guidelines and consider how recent evidence is changing practice.
Continuing Education Instructions and Disclosure Information
Contact hours available until 10/28/2020.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner
Speakers Conflict of Interest Disclosure: There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
After completing this continuing nursing education activity the learner will be able to differentiate between the current AUA guidelines for AMH in adults and the ACOG/AUGS recommendations for AMH evaluation in women.